SARS-Coronavirus Nucleocapsid Protein (SARS-CoV N) anticorps
Aperçu rapide pour SARS-Coronavirus Nucleocapsid Protein (SARS-CoV N) anticorps (ABIN7478588)
Antigène
Voir toutes SARS-Coronavirus Nucleocapsid Protein (SARS-CoV N) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Specificité
- Reactive with the NP of native SARS & MERS coronaviruses.
-
Réactivité croisée (Details)
- These antibodies are non-reactive with the following Coronavirus strains: 229E, NL63 & OC43.
-
Purification
- purified preparations consist of >90% pure mouse monoclonal antibody which has been purified from ascites fluid or culture medium by protein A chromatography or sequential differential precipitations.
-
Pureté
- 90,00 %
-
Isotype
- IgG1
-
-
-
-
Indications d'application
- Working dilution must be determined by the user. Suggested starting ranges are 1:10-1:50 for IFA and 1:20-1:200 for ELISA.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 100 μg/mL
-
Buffer
- The final preparation is formulated to a protein concentration of 100 μg/mL in 0.01 M phosphate buffered saline, pH 7.2 and contains 0.1 % sodium azide. No stabilizing proteins.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
- should be stored at 2-8°C until ready for use.
-
-
- SARS-Coronavirus Nucleocapsid Protein (SARS-CoV N)
-
Autre désignation
- SARS-Coronavirus Nucleocapsid Protein
-
Classe de substances
- Viral Protein
Antigène
-